Biopharmaceutics, pharmacokinetics and pharmacology of psoralens
- 31 December 1988
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 19 (5) , 649-653
- https://doi.org/10.1016/0306-3623(88)90122-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Clinical Pharmacokinetics of Methoxsalen and Other PsoralensClinical Pharmacokinetics, 1986
- Mutagenicity and Carcinogenicity of Methoxsalen Plus UV-AArchives of Dermatology, 1984
- Intraindividual and Interindividual variability in 8-methoxypsoralen kinetics and effect in psoriatic patientsClinical Pharmacology & Therapeutics, 1983
- Determination of Trimethylpsoralen in Blood, Ophthalmic Fluids, and SkinJournal of Investigative Dermatology, 1982
- Serum Levels of 8-Methoxypsoralen in Two Different Drug Preparations: Correlation with Photosensitivity and UV-A Dose Requirements for PhotochemotherapyJournal of Investigative Dermatology, 1982
- Plasma levels of 8-methoxypsoralen in psoriatic patients receiving topical 8-methoxypsoralenBritish Journal of Dermatology, 1982
- ORAL 8-METHOXYPSORALEN PHOTOCHEMOTHERAPY OF PSORIASISThe Lancet, 1981
- Reversible binding of 5- and 8-methoxypsoralen to human serum proteins (albumin) and to epidermis in vitroBritish Journal of Dermatology, 1979
- 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasisBritish Journal of Dermatology, 1979
- Oral Methoxsalen Photochemotherapy for The Treatment of Psoriasis: a Cooperative Clinical TrialJournal of Investigative Dermatology, 1977